Stay updated on Dapirolizumab Pegol Safety in Lupus Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.

Latest updates to the Dapirolizumab Pegol Safety in Lupus Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe record history view shows an updated latest version entry dated 2026-04-16/2026-04-17, with changes categorized under Study Status and Contacts/Locations. It also reflects a UI/app revision update (v3.5.3) and removes an older revision reference (v3.5.2) from the history list.SummaryDifference0.2%

- Check20 days agoChange DetectedAdded revision v3.5.2 to the record history and removed revision v3.5.0.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded Contacts/Locations and Study Status sections in the 2026-04-03 update; 2026-03-20 content was deleted.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded Contacts/Locations and Study Status entries; a deletion occurred on 2026-03-06.SummaryDifference0.2%

- Check49 days agoChange DetectedA new revision entry v3.5.0 was added to the record history, and the previous v3.4.3 entry was removed from the record history.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded Contacts/Locations and Study Status sections to the record history page and updated to Revision: v3.4.3.SummaryDifference0.2%

Stay in the know with updates to Dapirolizumab Pegol Safety in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.